30-Second Smart Briefing & Audio Digest
“A recent study suggests that a common menopause treatment may lower the risk of Alzheimer's disease by 35% in women. This finding has significant implications for the US market, as it could lead to a shift in the way menopause treatments are prescribed and marketed. The study's results also highlight the importance of hormone therapy in preventing age-related cognitive decline.”
Core Impact Points
Alzheimer's risk may be 35% lower with common menopause treatment, study finds Fox News Study ties estrogen-based menopausal hormone therapy to lower Alzheimer’s risk Stanford Medicine Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology National Institutes of Health (NIH) | (.
Want to read more from the original publisher?
Originally reported by Google News - Health
Create enterprise-grade marketing content, code summaries, and strategy reports 5x faster.
Be the first to react to this story!
Please sign in to leave a comment and share your opinion.
No comments yet. Be the first to start the conversation!
Most read & bookmarked this week